ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

TARO Taro Pharmaceutical Industries Ltd

42,73
-0,01 (-0,02%)
15 Jun 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Taro Pharmaceutical Industries Ltd TARO NYSE Common Stock
  Änderung Änderung % Aktuell Zeit
-0,01 -0,02% 42,73 02:00:00
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
42,71 42,65 42,77 42,73 42,74
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
23.5.202414:10PRNUSTaro Shareholders Approve Merger with Sun Pharma
23.5.202414:01EDGAR2Form SC 13E3/A - Going private transaction by certain..
23.5.202413:50PRNCATaro Shareholders Approve Merger with Sun Pharma
23.5.202413:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
21.5.202415:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
20.5.202423:00BWTaro Provides Results for Year Ended March 31, 2024
15.5.202415:00BWTaro to Release Full Year Results on May 20, 2024
14.5.202414:20EDGAR2Form SC 13E3/A - Going private transaction by certain..
08.5.202415:28EDGAR2Form SC 13E3/A - Going private transaction by certain..
08.5.202415:07BWLeading Independent Proxy Advisory Firms ISS and Glass Lewis..
15.4.202414:00BWTaro Announces Extraordinary General Meeting and Ordinary..
11.3.202411:19EDGAR2Form SC 13E3/A - Going private transaction by certain..
15.2.202414:36EDGAR2Form SC 13E3 - Going private transaction by certain issuers
30.1.202419:18PRNUSKuehn Law Encourages PGTI, TAST, TARO, and ANSS Investors to..
30.1.202413:00PRNUSKrensavage Asset Management Remains Opposed to Sun's..
26.1.202415:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
25.1.202423:06BWTaro Provides Results for December 31, 2023
19.1.202422:15BWTaro to Release Third Quarter Results on January 25, 2024
17.1.202422:36EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
17.1.202422:35EDGAR2Form SC 13D/A - General statement of acquisition of..
17.1.202422:30PRNCATaro Announces Merger Agreement with Sun Pharma
04.1.202422:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11.12.202322:31EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11.12.202322:30EDGAR2Form SC 13D/A - General statement of acquisition of..
17.11.202322:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
27.10.202315:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
26.10.202323:00BWTaro Provides Results for September 30, 2023
19.10.202322:30BWTaro to Release Second Quarter Results on October 26, 2023
27.7.202316:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
27.7.202302:36BWTaro Provides Results for the Quarter Ended June 30, 2023
19.7.202322:00BWTaro to Release First Quarter Results on July 26, 2023
19.7.202313:00PRNUSKrensavage Asset Management Opposes Sun's Lowball Bid for..
30.6.202315:00BWTaro Annual Report on Form 20-F Available For Fiscal Year..
29.6.202322:32EDGAR2Form 20-F - Annual and transition report of foreign private..
28.6.202323:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock